To test the importance of several of these molecules in TWEAK-mediated skin inflammation, we blocked CCL2, CCL5 and CCL7 together, by injecting neutralizing antibodies at the time of rTWEAK injection. The gene discussed is CCL5; the disease is dermatitis.